Take Advantage of OA Benefits

Open access gives everyone access to research results published in scholarly journals. Open access benefits researchers and society as a whole.

FinELib's goal is to increase and advance open access in its negotiations. More about the FinELib’s current OA deals and discounts below.

More information about open access benefits regarding specific publishers is available from your own library.

 

OA2

Instructions to the Corresponding Author

American Chemical Society: OA publishing

FinELib consortium’s agreement with ACS Publications offers authors an opportunity to publish their articles under an Open Access CC BY license for free using granted credits.

This means that there is no article processing charge for the author.

Elsevier: OA publishing

FinELib consortium’s agreement with Elsevier offers the researchers an opportunity to publish their articles open access with a discount in Elsevier journals.

The discount is 50 % of the journal’s APC-list price (APC = article processing charge).

Emerald: OA publishing

FinELib consortium’s agreement with Emerald offers authors an opportunity to publish their articles under the CC BY-license with a free open access voucher.

This means that there is no article processing charge for the author.

Royal Society of Chemistry: OA publishing

Researchers can publish their articles open access in RSC hybrid journals without additional payment, since the costs have been covered as a part of FinELib consortium’s agreement.

Sage: OA publishing

Researchers can publish their article open access in Sage journals with a discounted 200£ APC fee.

Science Advances journal: OA publishing

Researchers get a 15% discount of the APC fee of Science Advances -journal. Science Advances is an online-only open access journal.

Springer Nature: OA publishing

FinELib consortium’s agreement with Springer Nature includes open access publishing in Springer’s hybrid titles without article processing charge (APC).

Wolters Kluwer/Lippincott: OA Publishing

FinELib consortium’s agreement with Wolters Kluwer Health offers authors an opportunity to publish their articles under the CC BY or CC BY-NC-ND license with a free open access.

This means that there is no article processing charge for the author.

Take advantage of
open access benefits

During negotiations, open access benefits have been agreed upon regarding the journals of the following publishers:
American Chemical Society | Elsevier | Emerald | Royal Society of Chemistry | Sage | Science Advances | Springer Nature | Wolters Kluwer/Lippincott

More information about publisher- and organisation-specific open access benefits is also available from your own library.